Cytosorbents (CTSO) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts CTSO Hot Sheet
Join SI Premium – FREE
Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $9.4 million versus the consensus estimate of $11.03 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AppFolio (APPF) Tops Q2 EPS by 2c ; Offers Guidance
- Marten Transport (MRTN) Misses Q2 EPS by 2c
- Grupo Aeroportuario (ASR) Tops Q2 EPS by 438c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
